N-methyl-N-(trimethylsilyl)trifluoroacetamide → 2-[[[1-(2-Amino-4-thiazolyl)-2-[[1-[[[[3-[[(1,4-dihydro-6,7-dihydroxy-4-oxo-3-quinolinyl)carbonyl]amino]-2-oxo-1-imidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, diphenylmethyl ester

HRID 868149ノート

反応式

HRID 868149 の反応式
[OH:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][C:11]=1[OH:12])[NH:8][CH:7]=[C:6]([C:13]([NH:15][N:16]1[CH2:20][CH2:19][N:18]([S:21]([NH:24][C:25]([N:27]3[CH2:30][CH:29]([NH:31][C:32](=[O:41])OCC4C=CC=CC=4)[C:28]3=[O:42])=[O:26])(=[O:23])=[O:22])[C:17]1=[O:43])=[O:14])[CH2:5]2.CN([Si](C)(C)C)C(=[O:51])C(F)(F)F.[NH2:56][C:57]1[S:58][CH:59]=[C:60](/[C:62](=[N:66]/[O:67][C:68]([CH3:86])([CH3:85])[C:69]([O:71][CH:72]([C:79]2[CH:84]=[CH:83][CH:82]=[CH:81][CH:80]=2)[C:73]2[CH:78]=[CH:77][CH:76]=[CH:75][CH:74]=2)=[O:70])/C(O)=O)[N:61]=1>CN(C)C=O.[Pd]>[NH2:56][C:57]1[S:58][CH:59]=[C:60]([C:62](=[N:66][O:67][C:68]([CH3:86])([CH3:85])[C:69]([O:71][CH:72]([C:79]2[CH:84]=[CH:83][CH:82]=[CH:81][CH:80]=2)[C:73]2[CH:74]=[CH:75][CH:76]=[CH:77][CH:78]=2)=[O:70])[C:32]([NH:31][CH:29]2[CH2:30][N:27]([C:25]([NH:24][S:21]([N:18]3[CH2:19][CH2:20][N:16]([NH:15][C:13]([C:6]4[C:5](=[O:51])[C:4]5[C:9](=[CH:10][C:11]([OH:12])=[C:2]([OH:1])[CH:3]=5)[NH:8][CH:7]=4)=[O:14])[C:17]3=[O:43])(=[O:23])=[O:22])=[O:26])[C:28]2=[O:42])=[O:41])[N:61]=1

参加物

6

反応物 3

HCID 32510N-methyl-N-(trimethylsilyl)trifluoroacetamideHCID 135359672-Amino-alpha-((2-(diphenylmethoxy)-1,1-dimethyl-2-oxoethoxy)imino)thiazol-4-acetic acidHCID 86742476[1-[[[[3-[[(1,4-Dihydro-6,7-dihydroxy-3-quinolinyl)carbonyl]amino]-2-oxo-1-imidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]carbamic acid, phenylmethyl ester

生成物 1

HCID 867424752-[[[1-(2-Amino-4-thiazolyl)-2-[[1-[[[[3-[[(1,4-dihydro-6,7-dihydroxy-4-oxo-3-quinolinyl)carbonyl]amino]-2-oxo-1-imidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid, diphenylmethyl ester

試薬・触媒・溶媒 2

HCID 23938Palladium触媒HCID 6228Dimethylformamide溶媒2 回

実験手順

To a solution of [1-[[[[3-[[(1,4-dihydro-6,7-dihydroxy-3-quinolinyl)carbonyl]amino]-2-oxo-1-imidazolidinyl]sulfonyl]amino]carbonyl]-2-oxo-3-azetidinyl]carbamic acid, phenylmethyl ester (3.35 g, 5.3 mmol) in 60 ml of N,N-dimethylformamide, N-methyl-N-trimethylsilyl trifluoroacetamide (5.28 g, 26.5 mmol) was added. After 30 minutes, 1.68 g of palladium on carbon was added, and the mixture was hydrogenolyzed for 1 hour. The catalyst was removed by filtration and the filtrate added to a solution of (Z)-2-amino-α-[[2-(diphenylmethoxy)-1,1-dimethyl-2-oxoethoxy]imino]-4-thiazoleacetic acid, 1-benzotriazole ester (2.96 g, 5.3 mmol) in 30 ml of N,N-dimethylformamide. After stirring for 20 hours, the solvent was distilled off and the residue triturated with 60 ml of water and 75 ml of ethyl acetate. The resulting crystals were filtered off, washed with water and dried in vacuo to give 3.27 g of the title compound.

後処理

  1. waitthe mixture was hydrogenolyzed for 1 hour
  2. customThe catalyst was removed by filtration
  3. distillationthe solvent was distilled off
  4. customthe residue triturated with 60 ml of water and 75 ml of ethyl acetate
  5. filtrationThe resulting crystals were filtered off
  6. washwashed with water
  7. customdried in vacuo

出典と根拠

ORDレコード
ord-a63c0aea668a424c99324d7eb3442978
出典データセット
uspto-grants-1988_10
特許番号
US04777252

反応ノート

読み込み中…